Table 2 Factors associated with overall survival
Characteristics | N | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|---|
HR | 95% CI | P | Adjusted HR | 95% CI | P | ||
Age, years | |||||||
 <50 | 39 | 1 (Ref) | − | − | 1 (Ref) | − | − |
 ≥50 | 89 | 2.848 | 0.825−9.835 | 0.098 | 2.407 | 0.668−8.670 | 0.179 |
FIGO stage | |||||||
 III | 77 | 1 (Ref) | − | − | 1 (Ref) | − | − |
 IV | 51 | 2.055 | 0.734−5.753 | 0.170 | 1.248 | 0.434−3.591 | 0.682 |
Primary treatment strategy | |||||||
 PDS | 79 | 1 (Ref) | − | − | 1 (Ref) | − | − |
 NAC | 49 | 3.790 | 1.483−9.691 | 0.005 | 4.098 | 1.478−11.359 | 0.007 |
Residual tumor after PDS/IDS | |||||||
 Optimal debulking | 109 | 1 (Ref) | − | − | 1 (Ref) | − | − |
 Suboptimal debulking | 19 | 1.723 | 0.545−5.442 | 0.354 | 1.935 | 0.559−6.703 | 0.298 |
BRCA status | |||||||
 Wild-type | 77 | 1 (Ref) | − | − | 1 (Ref) | − | − |
 Mutation | 51 | 0.584 | 0.228−1.495 | 0.262 | 0.768 | 0.283−2.082 | 0.603 |